Biodexa Share Count Up 1,592% in Nine Months on Serial Warrant Treadmill

Four dilutive transactions in ten weeks with a single counterparty have ballooned Biodexa's ADS count from roughly 452,000 to 7.6 million, and 4.4 million more warrants can be repriced at the company's discretion.